JACN
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Clark, W. F.
Right arrow Articles by Parbtani, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Clark, W. F.
Right arrow Articles by Parbtani, A.

Flaxseed in Lupus Nephritis: A Two-Year Nonplacebo-Controlled Crossover Study

William F. Clark, MD, Claude Kortas, MD, A. Paul Heidenheim, MSoc, Jocelyn Garland, MD, Evelyn Spanner, RPDt and Anwar Parbtani, PhD

London Health Sciences Centre, Westminster Campus, The University of Western Ontario, London, Ontario, CANADA



View larger version (16K):

[in a new window]
  		Fig. 1. Serum alpha-linolenic acid levels in lupus patients consuming 30g of flaxseed a day according to the level of patient compliance, noncompliance and/or nonparticipation. a. Values obtained in all groups of patients at the various phases of the study. It is impossible to explain the alpha-linolenic acid pattern of the start flaxseed group except on the basis of noncompliance since their levels are lower when taking flaxseed. This curve led us to isolate the nine patients who demonstrated the expected rise in alpha-linolenic acid when on flaxseed and a drop when off flaxseed. b. Values obtained in the compliant patients at the different phases of the study.

 




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by the American College of Nutrition.